Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $13.38 million. The enterprise value is $22.31 million.
Important Dates
The last earnings date was Friday, November 13, 2026, before market open.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLR has 15.91 million shares outstanding. The number of shares has increased by 39.04% in one year.
| Current Share Class | 15.91M |
| Shares Outstanding | 15.91M |
| Shares Change (YoY) | +39.04% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | 6.80% |
| Float | 15.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 38.23 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 63.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.91
| Current Ratio | 0.91 |
| Quick Ratio | 0.54 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.83 |
Financial Efficiency
Return on equity (ROE) is -322.66% and return on invested capital (ROIC) is -50.44%.
| Return on Equity (ROE) | -322.66% |
| Return on Assets (ROA) | -35.88% |
| Return on Invested Capital (ROIC) | -50.44% |
| Return on Capital Employed (ROCE) | 609.37% |
| Weighted Average Cost of Capital (WACC) | 7.09% |
| Revenue Per Employee | $43,750 |
| Profits Per Employee | -$1.97M |
| Employee Count | 8 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.73% in the last 52 weeks. The beta is 0.57, so ALLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | -28.73% |
| 50-Day Moving Average | 0.99 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 40.31 |
| Average Volume (20 Days) | 141,536 |
Short Selling Information
The latest short interest is 230,750, so 1.45% of the outstanding shares have been sold short.
| Short Interest | 230,750 |
| Short Previous Month | 168,026 |
| Short % of Shares Out | 1.45% |
| Short % of Float | 1.46% |
| Short Ratio (days to cover) | 1.86 |
Income Statement
In the last 12 months, ALLR had revenue of $350,000 and -$15.73 million in losses. Loss per share was -$0.99.
| Revenue | 350,000 |
| Gross Profit | 350,000 |
| Operating Income | -13.78M |
| Pretax Income | -15.73M |
| Net Income | -15.73M |
| EBITDA | -13.77M |
| EBIT | -13.78M |
| Loss Per Share | -$0.99 |
Full Income Statement Balance Sheet
The company has $14.09 million in cash and $23.02 million in debt, with a net cash position of -$8.93 million or -$0.56 per share.
| Cash & Cash Equivalents | 14.09M |
| Total Debt | 23.02M |
| Net Cash | -8.93M |
| Net Cash Per Share | -$0.56 |
| Equity (Book Value) | -2.26M |
| Book Value Per Share | -0.14 |
| Working Capital | -2.62M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$13.18 million and capital expenditures -$72,000, giving a free cash flow of -$13.25 million.
| Operating Cash Flow | -13.18M |
| Capital Expenditures | -72,000 |
| Depreciation & Amortization | 13,000 |
| Net Borrowing | 20.00M |
| Free Cash Flow | -13.25M |
| FCF Per Share | -$0.83 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -3,938.29% |
| Pretax Margin | -4,493.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -39.04% |
| Shareholder Yield | -39.04% |
| Earnings Yield | -117.26% |
| FCF Yield | -99.01% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on September 11, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Sep 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |